Advertisement

Topics

Innate immune adaptor TRIF confers neuroprotection in ALS

20:00 EDT 14 Apr 2018 | AAAS

(Nagoya University) Researchers led by Nagoya University report that deficiency of the innate immune adaptor TIR domain-containing adaptor inducing interferon-β (TRIF) significantly shortens survival time and accelerates disease progression of ALS mice. They revealed for the first time that the TRIF pathway is involved in eliminating aberrantly activated astrocytes to maintain the microenvironment surrounding motor neurons in ALS mice. This study provides a clue to develop a new therapeutic approach for protecting ALS motor neurons.

Original Article: Innate immune adaptor TRIF confers neuroprotection in ALS

NEXT ARTICLE

More From BioPortfolio on "Innate immune adaptor TRIF confers neuroprotection in ALS"

Advertisement
Quick Search
Advertisement
Advertisement